Tolerability, Efficacy, and Safety of Pegylated Liposomal Doxorubicin in Combination with Carboplatin Versus Gemcitabine–Carboplatin for the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer: A Systematic Review

OBJECTIVE. To compare the tolerability, efficacy, and safety profiles of pegylated liposomal doxorubicin in combination with carboplatin (PLD–Carbo) with those of gemcitabine–carboplatin (Gem–Carbo) for the treatment of patients with platinum-sensitive recurrent ovarian cancer (PSROC) by reviewing t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Holloway, Robert W., Grendys, Edward C., Lefebvre, Patrick, Vekeman, Francis, McMeekin, Scott
Format: Artigo
Idioma:Inglês
Publicat: AlphaMed Press 2010
Matèries:
Gynecologic Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3227899/
https://ncbi.nlm.nih.gov/pubmed/20930103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2009-0331
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars